Publication:
Perceptions about the Management of Patients with DM2 and COVID-19 in the Hospital Care Setting.

dc.contributor.authorGómez-Huelgas, Ricardo
dc.contributor.authorGomez-Peralta, Fernando
dc.date.accessioned2023-05-03T14:08:55Z
dc.date.available2023-05-03T14:08:55Z
dc.date.issued2022-08-02
dc.description.abstractCOVID-19 entails a higher rate of complications in subjects with type 2 diabetes mellitus (T2DM). Likewise, COVID-19 infection can cause alterations in glucose metabolism that may lead to worse control. The aim of the study was to analyse the perceptions of a large group of Spanish physicians about the relationship between COVID-19 and T2DM, as well as the management, monitoring, and treatment of both diseases. A cross-sectional multicenter national project was conducted based on a survey which included opinion, attitude, and behavior (OAB) questions. Physicians specialised in internal medicine or endocrinology, whose usual clinical practices included the management of T2DM, responded to the survey between March and April 2021. A total of 112 participants responded to the survey, from which 64.3% believed that COVID-19 entailed a higher risk of glycaemic decompensation irrespective of the presence of previously known T2DM. Obesity was considered a risk factor for poor control of T2DM by 57.7% and for a worse course of COVID-19 by 61.0%. Treatment intensification in not-on-target patients was considered by 57.1% in the presence of COVID-19 and by 73.2% in the absence of COVID-19. No participants considered the suspension of dipeptidyl peptidase 4 inhibitors (DPP-4i) in ambulatory patients, 85.7% declared that this therapeutic approach in hospitalized patients should be kept, and 88.4% supported the option of maintaining DPP-4i when corticosteroids were prescribed. The physicians involved in the management of T2DM and COVID-19 are aware of the bidirectional relationship between both conditions. However, the monitoring and therapeutic management of patients with T2DM who are infected by SARS-CoV-2 needs improvement through the following of the current recommendations and available evidence.
dc.description.versionSi
dc.identifier.citationGómez-Huelgas R, Gómez-Peralta F. Perceptions about the Management of Patients with DM2 and COVID-19 in the Hospital Care Setting. J Clin Med. 2022 Aug 2;11(15):4507
dc.identifier.doi10.3390/jcm11154507
dc.identifier.issn2077-0383
dc.identifier.pmcPMC9369585
dc.identifier.pmid35956122
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369585/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2077-0383/11/15/4507/pdf?version=1659597760
dc.identifier.urihttp://hdl.handle.net/10668/21327
dc.issue.number15
dc.journal.titleJournal of clinical medicine
dc.journal.titleabbreviationJ Clin Med
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number14
dc.provenanceRealizada la curación de contenido 28/04/2025
dc.publisherMDPI
dc.pubmedtypeJournal Article
dc.relation.publisherversionhttps://www.mdpi.com/resolver?pii=jcm11154507
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAmbulatory care
dc.subjectComorbidity
dc.subjectCoronavirus infections
dc.subjectDiabetes complications
dc.subjectDiabetes mellitus
dc.subjectHospitalization
dc.subjectHypoglycemic agents
dc.subjectType 2
dc.subject.decsDiabetes Mellitus tipo 2
dc.subject.decsGlucosa
dc.subject.decsMetabolismo
dc.subject.decsObesidad
dc.subject.decsEndocrinología
dc.subject.decsCorticoesteroides
dc.subject.meshDipeptidyl-Peptidase IV Inhibitors
dc.subject.meshSARS-CoV-2
dc.subject.meshCOVID-19
dc.subject.meshInternal Medicine
dc.subject.meshAdrenal Cortex Hormones
dc.subject.meshObesity
dc.titlePerceptions about the Management of Patients with DM2 and COVID-19 in the Hospital Care Setting.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC9369585.pdf
Size:
1.85 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Gomez-Huelga_PerceptionsAbout_MaterialSuplementario.zip
Size:
3.92 MB
Format: